Hirofumi Kai
- Immunology top 2%
- Immune Response and Inflammation 20
- Microbiology top 2%
- Cancer Research top 5%
- Emergency Medical Services top 1%
- Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease 17
-
- Neonatal Respiratory Health Research 25
- Cystic Fibrosis Research Advances 22
- Respiratory and Cough-Related Research 15
-
- Asthma and respiratory diseases 16
-
- Glycosylation and Glycoproteins Research 15
- Heat shock proteins research 14
- Co-authors
- Tsuyoshi ShutoMary Ann SuicoJiandong LiHirofumi JonoTomoaki KogaHaidong XuYoichiro IsohamaTakashi Sato
- Journals
- Journal of Biological Chemistry (21 papers)Biochemical and Biophysical Research Communications (17 papers)Journal of Pharmacological Sciences (13 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hirofumi Kai
219 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 132
- Immunology 1.4k
- Microbiology 266
- Cancer Research 536
- Emergency Medical Services 243
- Cell Biology 529
Countries citing papers authored by Hirofumi Kai
This map shows the geographic impact of Hirofumi Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Kai more than expected).
Fields of papers citing papers by Hirofumi Kai
This network shows the impact of papers produced by Hirofumi Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Kai. The network helps show where Hirofumi Kai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirofumi Kai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 11 | |
| 7 | 2015 | 98 | |
| 8 | 2012 | 37 | |
| 9 | 2012 | 61 | |
| 10 | 2008 | 45 | |
| 11 | Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. | 2005 | 5 |
| 12 | 2005 | 160 | |
| 13 | 2005 | 25 | |
| 14 | Bakumondo-to (Mai-Men-Dong-Tang) increases intracellular cAMP in alveolar type II cells : Bakumondo-to stimulates production and inhibits degradation of cAMP | 2001 | 1 |
| 15 | Bakumondo-to (Mai-Men-Dong-Tang) increases β_1-adrenergic receptor mRNA expression in rat alveolar type II cells | 2001 | 0 |
| 16 | 2000 | 33 | |
| 17 | 1997 | 15 | |
| 18 | 1995 | 3 | |
| 19 | 1993 | 3 | |
| 20 | 1986 | 8 |
About Hirofumi Kai
Hirofumi Kai is a scholar working on Aging, Immunology and Allergy, Endocrine and Autonomic Systems, Immunology and Pulmonary and Respiratory Medicine, having authored 228 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (25 papers), Cystic Fibrosis Research Advances (22 papers), Immune Response and Inflammation (20 papers), Endoplasmic Reticulum Stress and Disease (17 papers), Asthma and respiratory diseases (16 papers), Glycosylation and Glycoproteins Research (15 papers), Respiratory and Cough-Related Research (15 papers) and Heat shock proteins research (14 papers). The work is most often cited by research in Immunology (1.4k citations), Microbiology (266 citations), Cancer Research (536 citations), Emergency Medical Services (243 citations) and Cell Biology (529 citations). Hirofumi Kai has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tsuyoshi Shuto, Mary Ann Suico, Jiandong Li, Hirofumi Jono, Tomoaki Koga, Haidong Xu, Yoichiro Isohama, Takashi Sato, Takeshi Miyata and David Lim. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Journal of Pharmacological Sciences, European Journal of Pharmacology and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.